In this review:
Polyphenol-rich dietary supplement for prostate cancer?
Aflibercept: no survival benefit in mCRPC
Abiraterone acetate prolongs survival in mCRPC
Metformin: an apparent benefit in prostate cancer
Genomic heterogeneity of CTCs in CRPC
The prognostic significance of CTCs
Prostate-specific mRNA detection: prognostic biomarker in CRPC
Please login below to download this issue (PDF)